Daniel Antonio Perez Sells 45,456 Shares of Hinge Health (NYSE:HNGE) Stock

Hinge Health Inc. (NYSE:HNGE) CEO Daniel Antonio Perez sold 45,456 shares of the business’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $55.05, for a total transaction of $2,502,352.80. Following the sale, the chief executive officer owned 35,470 shares in the company, valued at $1,952,623.50. This trade represents a 56.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Daniel Antonio Perez also recently made the following trade(s):

• On Wednesday, May 6th, Daniel Antonio Perez sold 104,544 shares of Hinge Health stock. The shares were sold at an average price of $55.09, for a total transaction of $5,759,328.96.
• On Thursday, February 12th, Daniel Antonio Perez sold 166,665 shares of Hinge Health stock. The shares were sold at an average price of $40.26, for a total transaction of $6,709,932.90.

Hinge Health Trading Up 1.6%

NYSE:HNGE traded up $0.89 during midday trading on Friday, hitting $55.89. 1,861,078 shares of the stock were exchanged, compared to its average volume of 1,251,254. The company has a market capitalization of $4.40 billion and a price-to-earnings ratio of -4.53. Hinge Health Inc. has a one year low of $30.08 and a one year high of $62.18. The business has a 50-day moving average price of $42.81 and a two-hundred day moving average price of $44.00.

Hinge Health (NYSE:HNGE) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.33. Hinge Health had a negative return on equity of 279.39% and a negative net margin of 78.95%.The firm had revenue of $182.31 million during the quarter. During the same period in the previous year, the business posted $1.30 earnings per share. The business’s revenue for the quarter was up 47.2% compared to the same quarter last year. Sell-side analysts forecast that Hinge Health Inc. will post 0.78 EPS for the current fiscal year.

Institutional Investors Weigh In On Hinge Health

Large investors have recently made changes to their positions in the company. Wells Fargo & Company MN lifted its position in shares of Hinge Health by 160.0% in the 4th quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock valued at $25,000 after acquiring an additional 336 shares in the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in Hinge Health during the 4th quarter valued at $26,000. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Hinge Health during the 3rd quarter valued at $37,000. CENTRAL TRUST Co purchased a new stake in shares of Hinge Health in the first quarter valued at $37,000. Finally, First Horizon Corp boosted its position in shares of Hinge Health by 163.9% in the fourth quarter. First Horizon Corp now owns 855 shares of the company’s stock worth $40,000 after buying an additional 531 shares during the period.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Needham & Company LLC upped their price target on shares of Hinge Health from $59.00 to $63.00 and gave the company a “buy” rating in a report on Wednesday. Freedom Capital raised shares of Hinge Health to a “strong-buy” rating in a research note on Thursday, January 22nd. Truist Financial set a $79.00 target price on shares of Hinge Health in a report on Wednesday. KeyCorp set a $55.00 price target on Hinge Health in a report on Wednesday, February 11th. Finally, Wells Fargo & Company increased their price objective on Hinge Health from $68.00 to $80.00 and gave the company an “overweight” rating in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $67.40.

Hinge Health Company Profile

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.